Catalyst Wire Dossier Catalyst Wire Dossier

Biotin-Acridine

· Cerus Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biotin-Acridine, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Biotin-Acridine Red Cell Exchange Kinetics [Phase 2]

See pricing